Clik here to view.
Insys Therapeutics to Present at the 2013 JMP Securities Healthcare Conference
PHOENIX, AZ–(Marketwired – Jul 2, 2013) – Insys Therapeutics, Inc. ( NASDAQ: INSY), a specialty pharmaceutical company that develops and commercializes innovative supportive care products, today...
View ArticleThe Medicines Company Announces Positive Results for Solo II Trial of...
PARSIPPANY, NJ–(Marketwired – Jul 2, 2013) – The Medicines Company (NASDAQ: MDCO) today announced results for its Phase 3 SOLO clinical trial program of oritavancin, which is under investigation for...
View ArticleClik here to view.
Paladin Labs Acquires Binotal(R) in Latin America From Bayer
MONTREAL, CANADA–(Marketwired – Jul 2, 2013) – Paladin Labs Inc. (TSX:PLB), a leading Canadian specialty pharmaceutical company, today announced that it has signed an agreement with Bayer to acquire...
View ArticleClik here to view.
Miraculins Executes Final Agreement for Acquisition of VeraLight’s SCOUT...
Test to Assist in Global Screening of World’s Fastest Growing Disease WINNIPEG, MANITOBA–(Marketwired – Jul 2, 2013) – Miraculins Inc. (TSX VENTURE:MOM),(“Miraculins” or the “Company”), a medical...
View ArticleHorizon Pharma to Present at the 8th Annual JMP Securities Healthcare Conference
DEERFIELD, IL–(Marketwired – Jul 2, 2013) – Horizon Pharma, Inc. (NASDAQ: HZNP), today announced that Timothy P. Walbert, chairman, president and chief executive officer will present at the 8th Annual...
View ArticleClik here to view.
REPEAT: EnWave Signs Commercial License with Hormel Foods Corporation
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Jul 2, 2013) – EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) (“EnWave” or the “Company”) is pleased to announce it has signed a royalty-bearing...
View ArticleClik here to view.
Sirona Biochem Announces LOI for Collaboration with Biogalenys
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Jul 2, 2013) – Sirona Biochem Corp. (TSX VENTURE:SBM)(OTCQX:SRBCF)(FRANKFURT:ZSB) is pleased to announce the signing of a Letter of Intent (LOI) for a...
View ArticleClik here to view.
Thallion’s Annual and Special Meeting to Be Held August 6, 2013
Shareholders to Vote on Acquisition by BELLUS MONTREAL, QUEBEC–(Marketwired – Jul 2, 2013) – Thallion Pharmaceuticals Inc. (TSX VENTURE:TLN) (“Thallion”) announced today that the Superior Court of...
View ArticleClik here to view.
Bioheart Announces Phase III MIRROR Trial for MyoCell Initiated
SUNRISE, FL–(Marketwired – Jul 2, 2013) – Bioheart, Inc. ( OTCQB: BHRT) announced today the successful enrollment and randomization of the first patient in the Phase III MIRROR Trial using MyoCell® or...
View ArticleClik here to view.
DelMar Pharma Receives Notice of Allowance on Key Patent for VAL-083 From the...
U.S. Patent Is the First to Issue as Part of an International Intellectual Property Strategy Around VAL-083 VANCOUVER, BC and MENLO PARK, CA–(Marketwired – Jul 2, 2013) - DelMar Pharmaceuticals, Inc....
View ArticleClik here to view.
Pyng Medical Corp. Announces Grant of Stock Options
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Jul 2, 2013) – Pyng Medical Corp. (TSX VENTURE:PYT) (the ” Company“) today announced that on July 1, 2013 it has granted a total of 145,000 options to...
View ArticleClik here to view.
Prana Receives Approval for 12-Month Open-Label Extension Study in...
MELBOURNE, AUSTRALIA–(Marketwired – Jul 3, 2013) – Prana Biotechnology ( NASDAQ: PRAN) ( ASX: PBT) today announced that it has received approval from the Austin Health Human Research Ethics Committee...
View ArticleCalyx Announces Increase in Size of Non-Brokered Private Placement
VANCOUVER, BRITISH COLUMBIA–(Marketwired – July 3, 2013) - THIS PRESS RELEASE, REQUIRED BY APPLICABLE CANADIAN LAWS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED...
View ArticleClik here to view.
EnWave Signs Collaboration Agreement With NDH Retail B.V. to Penetrate...
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Jul 3, 2013) – EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) (“EnWave”, or the “Company”)announced today that it has signed a Collaboration Agreement...
View ArticleClik here to view.
Imperial Ginseng Products Ltd. Announces Changes in Authorized Share...
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Jul 3, 2013) – Imperial Ginseng Products Ltd.(TSX VENTURE:IGP) (TSX VENTURE:IGP.PR.A) (the “Company”) is pleased to announce the following changes effective...
View ArticleClik here to view.
Qu Biologics Initiates Study of Site Specific Immunomodulators at Geisel...
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Jul 3, 2013) – Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to “reboot” the body’s immune system,...
View ArticleClik here to view.
Nanobiotix Announces EUR 2.8 Million Grant From bpifrance to Accelerate...
Through ETPN (European Technology Platform of Nanomedicine), Nanobiotix Is Driving Nanomedicine in Europe and Is Now Involved in the First Nanomedicine Consortium in France With the launch of NICE...
View ArticleNanobiotix Announces EUR 2.8 Million Grant From bpifrance to Accelerate...
PARIS–(Marketwired – Jul 3, 2013) – NANOBIOTIX (EURONEXT PARIS: NANO), a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announces today it has...
View ArticleClik here to view.
Lifetech Industries, Inc. Corporate Update
BELLEVUE, WA–(Marketwired – Jul 3, 2013) – Lifetech Industries, Inc. ( OTCBB: LTCH) is pleased to provide a corporate update with respect to the recently filed form 8-K with the SEC. On June 25th the...
View ArticleClik here to view.
Theratechnologies to Announce Second Quarter 2013 Financial Results
MONTREAL, QUEBEC–(Marketwired – Jul 3, 2013) – Theratechnologies Inc. (TSX:TH) (Theratechnologies) announced today that it will issue its financial results for the second quarter ended May 31, 2013,...
View Article
